StomaphyX

DEVICE2 trials

Sponsors

EndoGastric Solutions, University of Alberta

Conditions

Morbid ObesityObesity

Phase 2

Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma

CompletedNCT01025076

University of AlbertaMorbid Obesity

Start: 2009-02-28End: 2012-05-31Updated: 2017-03-10

Unknown Phase

StomaphyX Versus Sham for Revisional Surgery in Post-Roux-en-Y Patients to Reduce Regained Weight

TerminatedNCT00939055

EndoGastric SolutionsObesity

Start: 2009-07-31End: 2012-06-30Updated: 2020-11-23

Related Papers

StomaphyX vs a Sham Procedure for Revisional Surgery to Reduce Regained Weight in Roux-en-Y Gastric Bypass Patients

JAMA Surgery2014-02-1939 citations